Author: Nicole Gulinazzo
Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL
Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center
Dennis Cooper, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
Susan O’Brien, MD, University of California, Irvine, CA
Amy Burd, PhD, Vice President of Research and Strategy, and Alissa Gentile, MSN, RN, Director of the Clinical Trial Support Center at The Leukemia & Lymphoma Society
Brad Zebrack, PhD, MSW, The University of Michigan School of Social Work, Ann Arbor, MI